Business Description
US Physical Therapy Inc
NAICS : 621498
SIC : 8093
ISIN : US90337L1089
Share Class Description:
FRA:UPH: Ordinary SharesTotal Employee Number:
7,294Description
US Physical Therapy Inc through its subsidiaries operate outpatient physical therapy clinics that provide pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries. The principal payment sources for the clinics' services are managed care programs, commercial health insurance, Medicare/Medicaid, workers' compensation insurance, and proceeds from personal injury cases. Its operating segment includes Physical therapy operations and Industrial injury prevention services. The company generates maximum revenue from the Physical therapy operations segment.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.08 | |||||
Equity-to-Asset | 0.38 | |||||
Debt-to-Equity | 0.77 | |||||
Debt-to-EBITDA | 3.5 | |||||
Interest Coverage | 8.03 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | 2.58 | |||||
Beneish M-Score | -2.76 | |||||
WACC vs ROIC | ||||||
Growth Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 6.5 | |||||
3-Year EBITDA Growth Rate | 7.2 | |||||
3-Year EPS without NRI Growth Rate | -0.9 | |||||
3-Year FCF Growth Rate | 1.2 | |||||
3-Year Book Growth Rate | 9.1 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate Industry Rank | 11.57 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 7.78 |
Momentum Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 84.6 | |||||
9-Day RSI | 76.09 | |||||
14-Day RSI | 68.83 | |||||
3-1 Month Momentum % | -17.32 | |||||
6-1 Month Momentum % | -26.57 | |||||
12-1 Month Momentum % | -23.91 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 1.19 | |||||
Quick Ratio | 1.19 | |||||
Cash Ratio | 0.24 | |||||
Days Sales Outstanding | 30.44 | |||||
Days Payable | 3.46 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Dividend Yield % | 2.47 | |||||
Dividend Payout Ratio | 0.7 | |||||
3-Year Dividend Growth Rate | 3.2 | |||||
Forward Dividend Yield % | 2.47 | |||||
5-Year Yield-on-Cost % | 9.32 | |||||
3-Year Average Share Buyback Ratio | -5.2 | |||||
Shareholder Yield % | -1.41 |
Profitability Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 19.03 | |||||
Operating Margin % | 10.07 | |||||
Net Margin % | -0.26 | |||||
EBITDA Margin % | 13.02 | |||||
FCF Margin % | 8.38 | |||||
OCF Margin % | 10.5 | |||||
ROE % | -0.42 | |||||
ROA % | -0.17 | |||||
ROIC % | 5.35 | |||||
3-Year ROIIC % | 2.59 | |||||
ROC (Joel Greenblatt) % | 43.52 | |||||
ROCE % | 7.52 | |||||
Years of Profitability over Past 10-Year | 10 | |||||
Moat Score | 5 | |||||
Tariff Resilience Score | 9 |
GF Value Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 146.76 | |||||
Forward PE Ratio | 24.59 | |||||
PE Ratio without NRI | 28.22 | |||||
Shiller PE Ratio | 31.59 | |||||
Price-to-Owner-Earnings | 352.79 | |||||
PEG Ratio | 28.22 | |||||
PS Ratio | 1.4 | |||||
PB Ratio | 2.38 | |||||
Price-to-Free-Cash-Flow | 16.72 | |||||
Price-to-Operating-Cash-Flow | 13.34 | |||||
EV-to-EBIT | 21.79 | |||||
EV-to-EBITDA | 17.05 | |||||
EV-to-Forward-EBITDA | 19.49 | |||||
EV-to-Revenue | 2.22 | |||||
EV-to-Forward-Revenue | 1.72 | |||||
EV-to-FCF | 26.47 | |||||
Price-to-GF-Value | 0.68 | |||||
Price-to-Projected-FCF | 1.03 | |||||
Price-to-DCF (Earnings Based) | 2.44 | |||||
Price-to-DCF (FCF Based) | 1.45 | |||||
Price-to-Median-PS-Value | 0.59 | |||||
Earnings Yield (Greenblatt) % | 4.59 | |||||
FCF Yield % | 5.97 | |||||
Forward Rate of Return (Yacktman) % | 4.03 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
US Physical Therapy Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 683.698 | ||
| EPS (TTM) (€) | 0.432 | ||
| Beta | 0.5281 | ||
| 3-Year Sharpe Ratio | -0.64 | ||
| 3-Year Sortino Ratio | -0.81 | ||
| Volatility % | 25.35 | ||
| 14-Day RSI | 68.83 | ||
| 14-Day ATR (€) | 1.113113 | ||
| 20-Day SMA (€) | 57.025 | ||
| 12-1 Month Momentum % | -23.91 | ||
| 52-Week Range (€) | 49.6 - 80.5 | ||
| Shares Outstanding (Mil) | 15.22 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
US Physical Therapy Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
US Physical Therapy Inc Stock Events
| Event | Date | Price (€) | ||
|---|---|---|---|---|
| Third quarter earnings conference call for 2026 | 2026-11-06 10:30 | In 123 days | ||
| Third quarter earnings results for 2026 | 2026-11-06 | In 122 days | ||
| Second quarter earnings conference call for 2026 | 2026-08-07 10:30 | In 32 days | ||
| Second quarter earnings results for 2026 | 2026-08-06 | In 30 days | ||
| USD 0.460000 Cash Dividend | 2026-05-22 | 53.00 (+0.00%) | ||
| General meeting for 2026 | 2026-05-20 09:00 | 53.00 (+0.00%) | ||
| First quarter earnings conference call for 2026 | 2026-05-07 10:30 | 60.50 (+0.00%) | ||
| First quarter earnings results for 2026 | 2026-05-06 | 60.50 (+0.00%) | ||
| USD 0.460000 Cash Dividend | 2026-03-13 | 68.00 (+0.00%) | ||
| Annual report for 2025 | 2026-02-27 | 68.00 (+0.00%) |
Show
Entries
US Physical Therapy Inc Frequently Asked Questions
What is US Physical Therapy Inc(FRA:UPH)'s stock price today?
The current price of FRA:UPH is €63.00. The 52 week high of FRA:UPH is €80.50 and 52 week low is €49.60.
When is next earnings date of US Physical Therapy Inc(FRA:UPH)?
The next earnings date of US Physical Therapy Inc(FRA:UPH) is 2026-08-06 Est..
Does US Physical Therapy Inc(FRA:UPH) pay dividends? If so, how much?
The Dividend Yield %  of US Physical Therapy Inc(FRA:UPH) is 2.47% (As of Today), Highest Dividend Payout Ratio of US Physical Therapy Inc(FRA:UPH) was 0.89. The lowest was 0.11. And the median was 0.42. The  Forward Dividend Yield % of US Physical Therapy Inc(FRA:UPH) is 2.47%. For more information regarding to dividend, please check our Dividend Page.
Press Release
Articles on US Physical Therapy Inc
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers